Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Reich

Showing results (61-70 of 218) with videos related to

Pageof 22
Sort By:
European Journal of Immunology|April 1, 1991
A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segmentK Deusch, F Lüling, K Reich, et al.
Clinical and Experimental Dermatology|November 13, 2010
An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroidsT Dirschka, K Reich, R Bissonnette, et al.
The British Journal of Dermatology|November 20, 2009
Epidemiology and comorbidity of psoriasis in childrenM Augustin, G Glaeske, M A Radtke, et al.
Allergy|January 26, 2011
Prospective validation of 'Allergy-Control-SCORE(TM)': a novel symptom-medication score for clinical trialsD Häfner, K Reich, P M Matricardi, et al.
The British Journal of Dermatology|July 22, 2014
Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasisA Langenbruch, M A Radtke, M Krensel, et al.
The British Journal of Dermatology|May 12, 2010
Nail psoriasis in Germany: epidemiology and burden of diseaseM Augustin, K Reich, C Blome, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 2, 2021
Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3K Reich, J B Hansen, L Puig, et al.
The British Journal of Dermatology|July 12, 2020
Secukinumab 2-weekly vs. 4-weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN studyK Reich, A Körber, U Mrowietz, et al.
The British Journal of Dermatology|June 10, 2000
N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergyG A Westphal, K Reich, T G Schulz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2012
Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trialC Müller, A Berensmeier, H Hamm, et al.
Pageof 22

Showing results (61-70 of 218) with videos related to

Sort By:
Pageof 22
European Journal of Immunology|April 1, 1991
A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segmentK Deusch, F Lüling, K Reich, et al.
Clinical and Experimental Dermatology|November 13, 2010
An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroidsT Dirschka, K Reich, R Bissonnette, et al.
The British Journal of Dermatology|November 20, 2009
Epidemiology and comorbidity of psoriasis in childrenM Augustin, G Glaeske, M A Radtke, et al.
Allergy|January 26, 2011
Prospective validation of 'Allergy-Control-SCORE(TM)': a novel symptom-medication score for clinical trialsD Häfner, K Reich, P M Matricardi, et al.
The British Journal of Dermatology|July 22, 2014
Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasisA Langenbruch, M A Radtke, M Krensel, et al.
The British Journal of Dermatology|May 12, 2010
Nail psoriasis in Germany: epidemiology and burden of diseaseM Augustin, K Reich, C Blome, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 2, 2021
Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3K Reich, J B Hansen, L Puig, et al.
The British Journal of Dermatology|July 12, 2020
Secukinumab 2-weekly vs. 4-weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN studyK Reich, A Körber, U Mrowietz, et al.
The British Journal of Dermatology|June 10, 2000
N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergyG A Westphal, K Reich, T G Schulz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2012
Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trialC Müller, A Berensmeier, H Hamm, et al.
Pageof 22